Arrowhead Pharmaceuticals Inc (ARWR) Annual Income Statement (USD)
ARWR Quarterly Financials (USD)
Frequently Asked Questions About Arrowhead Pharmaceuticals Inc (ARWR) Stock
Arrowhead Pharmaceuticals Inc's (ARWR) last reported annual revenue was USD 240.74 Million.
Arrowhead Pharmaceuticals Inc's (ARWR) annual revenue growth rate based on the revenue reported in the past 5 years is : 71.68%
Arrowhead Pharmaceuticals Inc's(ARWR) is not profitable as of its last reported annual financials.
The net profit margin for Arrowhead Pharmaceuticals Inc's(ARWR) from its laster reported year is -85.27%
The return on equity (ROE) for Arrowhead Pharmaceuticals Inc's(ARWR) from its last reported annual financials is : -151.84%
The return on assets (ROA) for Arrowhead Pharmaceuticals Inc's(ARWR) from its last reported annual financials is : -40.72%
The return on invested capital (ROIC) for Arrowhead Pharmaceuticals Inc's(ARWR) from its last reported annual financials is : -110.14%
The Debt to Equity ratio for Arrowhead Pharmaceuticals Inc's(ARWR) from its last reported annual financials is : 0.00%
The dividend yield for Arrowhead Pharmaceuticals Inc's(ARWR) from its laster reported year is 0.00%
Arrowhead Pharmaceuticals Inc's(ARWR) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ARWR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
